ADIPOQ and type 2 diabetes mellitus: Similarly, a study by Esposito et al. (2011) found that thiazolidinedione treatment decreased circulating endothelial microparticles and increased serum adiponectin levels in 110 patients with newly diagnosed type 2 diabetes [18].